Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided for the purpose of scientific exchange.

The website is not country specific and may therefore contain information that is not applicable in your country, thus you may find information concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies. This website is not intended to promote in any way, any use, either approved, or unapproved, of a Novo Nordisk product or of any other product or serve as basis for any treatment decision or action. Please always refer to Summary of Product Characteristics (product label) as approved by regulatory authorities in your country or contact Novo Nordisk for further information.

Furthermore, the site is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. Only a physician can determine whether a specific product is correct for a particular patient. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site.

By accessing this website you accept this legal notice and expressly confirm your status as a healthcare professional.

Ronald
Goldenberg
LMC Diabetes & Endocrinology, Vaughan, Ontario, Canada

Dr Goldenberg is a consultant endocrinologist affiliated with LMC Diabetes & Endocrinology in Vaughan, Ontario. He completed his residency in Internal Medicine in 1987 and his fellowship in Endocrinology & Metabolism in 1989, both at the University of Toronto. His major areas of interest include clinical care of diabetes, obesity, dyslipidaemia and thyroid disorders.

 

Dr Goldenberg has been an investigator in a wide array of clinical trials in the areas of diabetes, hypertension, obesity and dyslipidaemia. He has been actively involved in Continuing Medical Education for the last 3 decades, with a strong focus on translating evidence-based medicine into practical patient care.

 

Dr Goldenberg was a councilor on the Diabetes Canada Clinical & Scientific Section Executive Committee from 2010 to 2016. He was also a member of the Steering Committee and an author for the 2013 CDA Clinical Practice Guidelines, lead author of the CDA March 2016 Interim Update and co-author of the November 2016 Interim Update on the Pharmacologic Management of Type 2 Diabetes. He has served on the Executive Committee and was an author for the 2018 Diabetes Canada Clinical Practice Guidelines.

 

Dr Goldenberg was affiliated with North York Branson/North York General Hospital from 1989 to 2020, where he served as Medical Director of the Diabetes Education Centre. He is Past-Chair of the Ontario Medical Association Section on Endocrinology & Metabolism and a previous President of the Toronto Diabetes Association.